TERN vs UAL · $6.12B cap vs P/E 10, rev $57.06B
Terns Pharmaceuticals Inc (TERN) versus United Airlines Holdings Inc (UAL) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
United Airlines Holdings Inc (UAL) is a airlines company listed on NASDAQ. It is led by Scott Kirby.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported UAL revenue for 2024-12-31 was $57.06B. Net income was $3.15B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
TERN currently screens at market cap $6.12B. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
Not investment advice. Open the TERN and UAL stock pages for the full models.
Not investment advice.